secwatch.observer — SEC 8-K summary
======================================

Issuer:     Polomar Health Services, Inc. (PMHS)
CIK:        0001265521
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001493152-25-002154
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Polomar Health amends license with Pinata; adds pharmacy sub, sets royalties of 10-20%
--------------------------------------------------------------------------------

- Amended license covers metformin (10% royalty), semaglutide/liraglutide (20%), sumatriptan/sildenafil (15%).
- License is worldwide, non-exclusive, perpetual; may be terminated with 180 days notice or for uncured breach.
- Polomar Specialty Pharmacy, a wholly-owned Florida subsidiary, added as a licensee.
- Pinata is an affiliate of CWR 1 LLC, Polomar's majority shareholder (common ownership).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/0001493152-25-002154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer